The ability to grow hair could be called the Holy Grail of the dermatology business, and it played a critical part in a "bet the company" biotech patent dispute.
At issue were therapies for skin care and hair growth, which generated three years of hard-fought litigation over the patents for making them.
The plaintiff company, SkinMedica, had sued Kay's clients Histogen Inc. and its founder Gail Naughton, for alleged patent infr...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In